A study looking at a new PET scan tracer for men with prostate cancer (FDHT study)
Cancer type:
Status:
Phase:
This study looked at a new radioactive injection (tracer) that you have before a PET scan to look for areas of prostate cancer.
It was for men with prostate cancer that has grown or spread to other parts of the body (progressive prostate cancer).
More about this trial
PET scans are a common cancer test. You might have one to:
- diagnose cancer
- show if the cancer has spread to other parts of the body
- find out how well treatment is working
Before you have a PET scan, you have an injection with a small amount of a radioactive drug called a tracer. The tracer is taken up by the cancer cells, which then show up on the scan.
In this study, researchers are looking at a new tracer called 18F-Dihydro-Testosterone ([18F]-FDHT). They think that it can show up prostate cancer cells better.
Everyone taking part in this study have up to 3 PET scans using the new tracer ([18F]-FDHT PET scan) and up to 3 MRI scans.
The main aims of this study are to:
- see where the tracer goes in your body
- find out how much of the tracer is taken up by prostate cancer cells before and after treatment
Summary of results
This trial was never finished so are no results available. This was because it was difficult to find enough people to take part.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Professor Wim Oyen
Supported by
The Royal Marsden Hospital NHS Foundation Trust
Movember Foundation
NIHR Clinical Research Network: Cancer
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040
